・Trump signed an executive order directing agencies to speed psychedelic research and approvals, alongside $50 million in federal funding for treatments such as ibogaine. ・FDA Commissioner Marty ...

The order eases restrictions on psychedelic drugs like ibogaine to spur research on using the them for medical purposes.

Military veterans may eventually see newer forms of mental health relief by way of treatments being greenlighted by the ...

The president’s executive order is intended to accelerate research into the compounds’ efficacy in treating mental health ...

Federal action signals growing recognition of psychedelic therapies’ potential to address urgent mental health challenges, including PTSD, ...

President Donald Trump announced new efforts to boost research into psychedelic drugs and make them available in controlled ...

The president will direct federal agencies to boost research into the drugs and support clinical trials, moves championed by ...

In 1943, a chemist in Switzerland synthesized a drug that alters consciousness. His discovery changed the study of medicine, ...

Researchers created a new questionnaire to measure major life changes linked to psychedelic use and found that most surveyed ...

Under federal law, cannabis is a Schedule I drug. According to this designation, cannabis has “a high potential for abuse” ...

Drug trials generally involve comparing a treatment with a nonactive, placebo version, an approach called "blinding" because ...